BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 30826891)

  • 1. Cardiac Complications in the Adult Bone Marrow Transplant Patient.
    Tuzovic M; Mead M; Young PA; Schiller G; Yang EH
    Curr Oncol Rep; 2019 Mar; 21(3):28. PubMed ID: 30826891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977-1997.
    Murdych T; Weisdorf DJ
    Bone Marrow Transplant; 2001 Aug; 28(3):283-7. PubMed ID: 11535997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic Toxicity of Chemoradiation.
    Armanious MA; Mishra S; Fradley MG
    Curr Oncol Rep; 2018 Apr; 20(6):45. PubMed ID: 29644475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology.
    Kostakou PM; Kouris NT; Kostopoulos VS; Damaskos DS; Olympios CD
    Heart Fail Rev; 2019 Jan; 24(1):91-100. PubMed ID: 30073443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.
    Garg V; Vorobiof G
    Curr Oncol Rep; 2016 Aug; 18(8):52. PubMed ID: 27461436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
    Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
    CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Follow-up of Hematopoietic Stem Cell Transplant Survivors: A Focus on Screening, Monitoring, and Therapeutics.
    Saunders IM; Tan M; Koura D; Young R
    Pharmacotherapy; 2020 Aug; 40(8):808-841. PubMed ID: 32652612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardio-oncology: a multidisciplinary approach for detection, prevention and management of cardiac dysfunction in cancer patients.
    Tajiri K; Aonuma K; Sekine I
    Jpn J Clin Oncol; 2017 Aug; 47(8):678-682. PubMed ID: 28505345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of the multidisciplinary team IntervenTion in cArdio-oNcology study (TITAN).
    Pituskin E; Haykowsky M; McNeely M; Mackey J; Chua N; Paterson I
    BMC Cancer; 2016 Sep; 16(1):733. PubMed ID: 27629548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal.
    Upshaw JN; O'Neill A; Carver JR; Dimond EP; Denlinger CS; Kircher SM; Wagner LI; Ky B; Brell JM
    Clin Colorectal Cancer; 2019 Mar; 18(1):44-51. PubMed ID: 30348619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of cardiac bio-markers in monitoring of cardiotoxicity after hematopoietic stem cell transplantation].
    Roziaková L; Mladosievičová B
    Vnitr Lek; 2013 Nov; 59(11):996-1002. PubMed ID: 24279444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotoxicity among adult survivors suffered from childhood malignancies.
    Petropoulos AC; Moschovi M
    Hell J Nucl Med; 2019; 22 Suppl 2():34-40. PubMed ID: 31802042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardio-oncology issues among pediatric cancer and stem cell transplant survivors.
    Hochberg JC; Cairo MS; Friedman DM
    Cardiol Rev; 2014; 22(6):268-74. PubMed ID: 24926805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardiotoxicity as undesired side effect in the treatment of breast cancer].
    Gramatyka M
    Postepy Hig Med Dosw (Online); 2014 May; 68():483-97. PubMed ID: 24864100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current perspectives of cardio-oncology: Epidemiology, adverse effects, pre-treatment screening and prevention strategies.
    Bychowski J; Sobiczewski W
    Cancer Med; 2023 Jul; 12(13):14545-14555. PubMed ID: 37102247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy-induced cardiotoxicity in children.
    Bansal N; Amdani S; Lipshultz ER; Lipshultz SE
    Expert Opin Drug Metab Toxicol; 2017 Aug; 13(8):817-832. PubMed ID: 28679288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac and cardiovascular consequences after haematopoietic stem cell transplantation.
    Tichelli A; Bhatia S; Socié G
    Br J Haematol; 2008 Jul; 142(1):11-26. PubMed ID: 18430191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echocardiographic evaluation of the early cardiotoxic effect of hematopoietic stem cell transplantation in patients with hematologic malignancies.
    Poręba M; Gać P; Usnarska-Zubkiewicz L; Pilecki W; Kuliczkowski K; Mazur G; Sobieszczańska M; Poręba R
    Leuk Lymphoma; 2016 Sep; 57(9):2119-25. PubMed ID: 26762118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late congestive heart failure after hematopoietic cell transplantation.
    Armenian SH; Sun CL; Francisco L; Steinberger J; Kurian S; Wong FL; Sharp J; Sposto R; Forman SJ; Bhatia S
    J Clin Oncol; 2008 Dec; 26(34):5537-43. PubMed ID: 18809605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.